Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Font

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|February 26, 2013
The expression of AIB1 correlates with cellular proliferation in human prolactinomasJosé Carretero, Enrique J Blanco, Manuel Carretero, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2020
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancerCarmen Salvador-Coloma, Ana Santaballa, Elena Sanmartín, et al.
Journal of Personalized Medicine|April 30, 2021
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric SarcomasAntonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics implementation in the clinics: information and guidelines for germline variantsGladys Olivera, Luis Sendra, María José Herrero, et al.
Molecular Oncology|November 30, 2020
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targetsEsther Coronado, Yania Yañez, Enrique Vidal, et al.
Scientific Reports|February 2, 2020
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Oncotargets and Therapy|December 7, 2019
Identification Of Actionable Genetic Targets In Primary Cardiac SarcomasCarmen Salvador-Coloma, María Saigí, Roberto Díaz-Beveridge, et al.
Scientific Reports|September 26, 2019
Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Clinical Epigenetics|March 14, 2015
Two independent epigenetic biomarkers predict survival in neuroblastomaYania Yáñez, Elena Grau, Virginia C Rodríguez-Cortez, et al.
American Journal of Clinical Pathology|December 16, 2003
Her-2/neu gene amplification in familial vs sporadic breast cancer. Impact on the behavior of the diseaseAna B Espinosa, Maria D Tabernero, Maria C García-Macías, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|February 26, 2013
The expression of AIB1 correlates with cellular proliferation in human prolactinomasJosé Carretero, Enrique J Blanco, Manuel Carretero, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2020
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancerCarmen Salvador-Coloma, Ana Santaballa, Elena Sanmartín, et al.
Journal of Personalized Medicine|April 30, 2021
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric SarcomasAntonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics implementation in the clinics: information and guidelines for germline variantsGladys Olivera, Luis Sendra, María José Herrero, et al.
Molecular Oncology|November 30, 2020
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targetsEsther Coronado, Yania Yañez, Enrique Vidal, et al.
Scientific Reports|February 2, 2020
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Oncotargets and Therapy|December 7, 2019
Identification Of Actionable Genetic Targets In Primary Cardiac SarcomasCarmen Salvador-Coloma, María Saigí, Roberto Díaz-Beveridge, et al.
Scientific Reports|September 26, 2019
Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Clinical Epigenetics|March 14, 2015
Two independent epigenetic biomarkers predict survival in neuroblastomaYania Yáñez, Elena Grau, Virginia C Rodríguez-Cortez, et al.
American Journal of Clinical Pathology|December 16, 2003
Her-2/neu gene amplification in familial vs sporadic breast cancer. Impact on the behavior of the diseaseAna B Espinosa, Maria D Tabernero, Maria C García-Macías, et al.
Pageof 5